Stock News: Defence Therapeutics - Groundbreaking results ahead

Cancer changes everything. Effective remedies against the scourge of our time would be a revolution. Defence Therapeutics is working to turn hope into fact: In the coming weeks, vaccines against cancer are to be combined with Accum, a drug enhancer patented by Defence, and then clinically tested. For the Company, this could mean a breakthrough at a time when the big players in the industry are paying close attention to innovative biotechs with a platform approach. With the help of facts and figures, we outline where Defence Therapeutics currently stands, which projects could ultimately result in a convincing overall picture and why the share has excellent prospects.

Den vollständigen Artikel lesen ...